{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:12:35Z","timestamp":1783948355982,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T00:00:00Z","timestamp":1601856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007344","name":"Achmea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007344","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical & Translational Endocrinology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jcte.2020.100237","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T12:32:32Z","timestamp":1602505952000},"page":"100237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Determinants of HbA1c reduction with FreeStyle Libre flash glucose monitoring (FLARE-NL 5)"],"prefix":"10.1016","volume":"22","author":[{"given":"A.","family":"Lameijer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Fokkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Edens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8583-376X","authenticated-orcid":false,"given":"R.J.","family":"Slingerland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.G.","family":"Bilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.R.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcte.2020.100237_b0005","doi-asserted-by":"crossref","unstructured":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:854\u201365.","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"10.1016\/j.jcte.2020.100237_b0010","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcte.2020.100237_b0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2016-000320","article-title":"Performance of the FreeStyle Libre Flash glucose monitoring system in patients with type 1 and 2 diabetes mellitus","volume":"5","author":"Fokkert","year":"2017","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jcte.2020.100237_b0020","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00125-019-4894-1","article-title":"Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes","volume":"62","author":"Tyndall","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcte.2020.100237_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107893","article-title":"Flash glucose monitoring: impact on markers of glycaemic control and patient-reported outcomes in individuals with type 1 diabetes mellitus in the real-world setting","volume":"157","author":"Nana","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jcte.2020.100237_b0030","doi-asserted-by":"crossref","unstructured":"Fokkert M, van Dijk P, Edens M, Barents E, Mollema J, Slingerland R, et al. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diabetes Res Care 2019;7, doi: 10.1136\/bmjdrc-2019-000809.","DOI":"10.1136\/bmjdrc-2019-000809"},{"key":"10.1016\/j.jcte.2020.100237_b0035","doi-asserted-by":"crossref","first-page":"4649303","DOI":"10.1155\/2019\/4649303","article-title":"Use of FreeStyle Libre flash monitor register in the netherlands (FLARE-NL1): patient experiences, satisfaction, and cost analysis","volume":"2019","author":"Fokkert","year":"2019","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.jcte.2020.100237_b0040","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Med Care"},{"key":"10.1016\/j.jcte.2020.100237_b0045","unstructured":"Van Reenen M, Janssen B. EQ-5D-3L User Guide: Basic Information on How to Use the EQ-5D-3L Instrument, EuroQol Research Foundation, Rotterdam, Netherlands; 2015."},{"key":"10.1016\/j.jcte.2020.100237_b0050","unstructured":"Lammers LM, Stalmeijer PFM, McDonnell J, et al. Kwaliteit van leven meten in economische evaluaties: het Nederlands EQ-5D-tarief Nederlands Tijdschrift Voor Geneeskunde, 2005;149(28):1574\u20138."},{"key":"10.1016\/j.jcte.2020.100237_b0055","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/dia.2010.0148","article-title":"One in five laboratories using various hemoglobin A1c methods do not meet the criteria for optimal diabetes care management","volume":"13","author":"Lenters-Westra","year":"2011","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcte.2020.100237_b0060","unstructured":"Internal Clinical Guidelines Team. Type 2 Diabetes in Adults: Management. London: National Institute for Health and Care Excellence (UK); 2015 Dec. (NICE Guideline, No. 28.) Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK338142\/. n.d."},{"key":"10.1016\/j.jcte.2020.100237_b0065","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-019-4894-1","article-title":"Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes","author":"Tyndall","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcte.2020.100237_b0070","unstructured":"https:\/\/www.zorginstituutnederland.nl\/publicaties\/standpunten\/2019\/12\/10\/fgm; n.d."},{"key":"10.1016\/j.jcte.2020.100237_b0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.diabres.2017.12.015","article-title":"Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: a European analysis of over 60 million glucose tests","volume":"137","author":"Dunn","year":"2018","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Journal of Clinical & Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623720300909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623720300909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:57:23Z","timestamp":1762005443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214623720300909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":15,"alternative-id":["S2214623720300909"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2020.100237","relation":{},"ISSN":["2214-6237"],"issn-type":[{"value":"2214-6237","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determinants of HbA1c reduction with FreeStyle Libre flash glucose monitoring (FLARE-NL 5)","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2020.100237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100237"}}